231 related articles for article (PubMed ID: 26969613)
1. Natural killer cells, ageing and cancer.
Naumova E; Pawelec G; Mihaylova A
Cancer Immunol Immunother; 2016 Apr; 65(4):367-70. PubMed ID: 26969613
[TBL] [Abstract][Full Text] [Related]
2. NK cell-based cancer immunotherapy: from basic biology to clinical application.
Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
[TBL] [Abstract][Full Text] [Related]
3. Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
Morandi F; Yazdanifar M; Cocco C; Bertaina A; Airoldi I
Cells; 2020 Jul; 9(8):. PubMed ID: 32707982
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell therapies.
Vivier E; Rebuffet L; Narni-Mancinelli E; Cornen S; Igarashi RY; Fantin VR
Nature; 2024 Feb; 626(8000):727-736. PubMed ID: 38383621
[TBL] [Abstract][Full Text] [Related]
6. Memory-like natural killer cells for cancer immunotherapy.
Gang M; Wong P; Berrien-Elliott MM; Fehniger TA
Semin Hematol; 2020 Oct; 57(4):185-193. PubMed ID: 33256911
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic role of natural killer cells in cancer.
Woan K; Reddy V
Expert Opin Biol Ther; 2007 Jan; 7(1):17-29. PubMed ID: 17150016
[TBL] [Abstract][Full Text] [Related]
8. NK cell-based cancer immunotherapy: from basic biology to clinical development.
Liu S; Galat V; Galat Y; Lee YKA; Wainwright D; Wu J
J Hematol Oncol; 2021 Jan; 14(1):7. PubMed ID: 33407739
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells and other innate lymphoid cells in cancer.
Chiossone L; Dumas PY; Vienne M; Vivier E
Nat Rev Immunol; 2018 Nov; 18(11):671-688. PubMed ID: 30209347
[TBL] [Abstract][Full Text] [Related]
10. [Natural killer cells: adaptation and memory in innate immunity].
Narni-Mancinelli E; Ugolini S; Vivier E
Med Sci (Paris); 2013 Apr; 29(4):389-95. PubMed ID: 23621934
[TBL] [Abstract][Full Text] [Related]
11. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.
Luevano M; Madrigal A; Saudemont A
Cell Mol Immunol; 2012 Jul; 9(4):310-20. PubMed ID: 22705914
[TBL] [Abstract][Full Text] [Related]
12. Leveraging natural killer cells for cancer immunotherapy.
Grossenbacher SK; Aguilar EG; Murphy WJ
Immunotherapy; 2017 May; 9(6):487-497. PubMed ID: 28472904
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells: can they be useful as adoptive immunotherapy for cancer?
Arai S; Klingemann HG
Expert Opin Biol Ther; 2005 Feb; 5(2):163-72. PubMed ID: 15757378
[TBL] [Abstract][Full Text] [Related]
14. Cellular therapy of cancer with natural killer cells-where do we stand?
Klingemann HG
Cytotherapy; 2013 Oct; 15(10):1185-94. PubMed ID: 23768925
[TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity.
Rafei H; Daher M; Rezvani K
Br J Haematol; 2021 Apr; 193(2):216-230. PubMed ID: 33216984
[TBL] [Abstract][Full Text] [Related]
16. Use of allogeneic NK cells for cancer immunotherapy.
Geller MA; Miller JS
Immunotherapy; 2011 Dec; 3(12):1445-59. PubMed ID: 22091681
[TBL] [Abstract][Full Text] [Related]
17. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
Pietra G; Vitale C; Pende D; Bertaina A; Moretta F; Falco M; Vacca P; Montaldo E; Cantoni C; Mingari MC; Moretta A; Locatelli F; Moretta L
Cancer Immunol Immunother; 2016 Apr; 65(4):465-76. PubMed ID: 26289090
[TBL] [Abstract][Full Text] [Related]
18. Targeting natural killer cells in cancer immunotherapy.
Guillerey C; Huntington ND; Smyth MJ
Nat Immunol; 2016 Aug; 17(9):1025-36. PubMed ID: 27540992
[TBL] [Abstract][Full Text] [Related]
19. Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.
Barrow AD; Colonna M
Semin Immunol; 2017 Jun; 31():30-36. PubMed ID: 28935344
[TBL] [Abstract][Full Text] [Related]
20. Current progress in NK cell biology and NK cell-based cancer immunotherapy.
Tarazona R; Lopez-Sejas N; Guerrero B; Hassouneh F; Valhondo I; Pera A; Sanchez-Correa B; Pastor N; Duran E; Alonso C; Solana R
Cancer Immunol Immunother; 2020 May; 69(5):879-899. PubMed ID: 32130453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
